Latest Distribution News

FortifAI has launched the production-ready version of its NOL8 AI Data Plane ahead of schedule, opening the door to paid enterprise proof-of-value engagements. The ASX-listed technology company ended September with A$17.3 million in cash and no debt, but still needs to convert technical validation into contracts and revenue.

Zuleika Gold will resume its exploration-led strategy after CZR Resources formally withdrew its all-scrip takeover offer. The company ended September debt-free with $42.1 million in cash and liquid assets, while assays and several drilling programmes remain ahead.

Axtec has moved several proptech partnerships towards commercial rollout, but its September quarter cash position leaves just 0.58 quarters of estimated funding. The company is pursuing strategic investment and expects an R&D rebate, neither of which has been secured in the filing.

FBR has converted its first Mantis welding robot sale into a binding A$990,000 order and secured a North American distributor. The commercial progress comes alongside A$2.073 million of quarterly operating cash burn and a reported 0.12 quarters of funding at period end.

Osteopore reported record quarterly revenue of A$859,000 in Q3 CY26 as it added market access in Thailand and Saudi Arabia and completed its first customised Hainan implant. The regenerative implant maker remains cash-flow negative, with A$712,000 in cash and A$14 million still available under its convertible note facility.

HALO Technologies reported a 21% quarterly revenue decline as weaker brokerage activity outweighed growth in subscriptions. A $5.34 million convertible note issue lifted cash to $3.07 million, but the company still reported a net operating cash outflow of $1.47 million.

Broken Hill Gold has increased the Vertigo resource by 43% while drilling continues to reveal high-grade gold-copper sulphides beneath White Dam’s Icebreaker prospect. The company ended September with A$12.6 million in cash, but its proposed production restart still depends on further drilling, refurbishment and mine economics.

Moonlight Resources has outlined a conceptual gold Exploration Target of up to 662,000 ounces at Clermont, while advancing drilling across gold and copper prospects. The company ended September with A$3.168 million in cash, equivalent to 1.1 quarters of funding at the reported spending rate.

LGP Cannatrek generated A$4.4 million in net operating cash flow on unaudited quarterly revenue of A$26.0 million, providing the first clean look at the merged group’s operations. Cost synergies, Danish production upgrades and UK expansion are advancing, while a pending TGA penalty remains an unresolved risk.

Proteomics International has begun the national rollout of its Promarker D and Promarker Eso blood tests through Healius, while a A$2 million tax incentive receipt has lifted pro forma cash to A$3.8 million. Promarker Endo also cleared an independent Oxford validation hurdle, but its commercial launch remains conditional.

EZZ Life Science cut its quarterly operating cash outflow sharply despite a 37.7% drop in customer receipts, as weaker Chinese e-commerce sales continued to weigh. EAORON skincare growth and a $9.16 million cash balance offer some support, but distributor collections and potential product returns remain unresolved.

Rivco Australia has reported a 1.2% quarterly decline in pre-tax NAV as softer water entitlement values offset the benefits of a more heavily leased portfolio. The company is shifting dividends towards operating earnings, while continuing its buyback at a substantial discount to NAV.